Indara Insurance PCL

Indara Insurance maintains a low debt-to-equity ratio of 0.03, indicating a conservative capital structure with minimal leverage. The company's liquidity position is assessed as low, with a price-to-book ratio of 0.47 and a price-to-tangible-book ratio of 0.47, suggesting the market values the company below its book value. Free cash flow is negative at -94.23 million THB, while operating cash flow remains positive at 370 million THB, indicating operational cash generation but capital outflows. Profitability metrics show a return on equity of 1.45% and a return on assets of 0.27%, both below the industry median for property and casualty insurers, which typically exceed 5% ROE and 1.5% ROA. Net income of 22.26 million THB and operating income of 4.8 million THB suggest modest earnings relative to total assets of 8.25 billion THB. The company's revenue is concentrated in Thailand, with no disclosed international operations, and its product mix is dominated by motor, personal accident, and health insurance. No material geographic diversification is evident in the financial snapshot, and segmental breakdowns are not provided in the latest filings. Outlook for the current fiscal year shows no significant revenue growth, with a flat trajectory expected. Free cash flow is projected to remain negative, and capital expenditures are minimal at -16.98 million THB. The company's growth strategy appears to focus on maintaining market share in its core domestic insurance segments rather than aggressive expansion. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and stable cash flow position reduce credit risk, but the negative free cash flow and low profitability metrics suggest operational efficiency challenges. No dilution sources were identified in the latest filings, and the probability of near-term dilution is assessed as low. Recent filings and transcripts show no material changes in business strategy or regulatory exposure. The company's 2023 annual report highlights continued focus on cost control and underwriting discipline, with no significant capital raising or restructuring activities disclosed.